CCL5 and stroke disorder: RANTES(−/−) mice or mice treated with anti-RANTES mAb showed significant reduction in inflammatory cytokines including IL-6, IL-10, TNF-α, MCP-I in IRI diseases, such as myocardial ischemia, stroke and hypoxia-related apnea syndrome10, 7, 9.